NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bumble Inc. ("Bumble" or the "Company") (NASDAQ:BMBL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bumble and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Groupon, Inc. ("Groupon" or the "Company") (NASDAQ:GRPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Groupon and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company") (NASDAQ:EWTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Edgewise and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of National Grid plc ("National Grid" or the "Company") (NYSE:NGG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether National Grid and certain of its

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ZEEKR Intelligent Technology Holding Limited ("Zeekr" or the "Company") (NYSE:ZK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zeekr and certain of its

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Geely Automobile Holdings Limited ("Geely" or the "Company") (OTCMKTS:GELYF; GELYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Geely and certain of its